Gettysburg Cancer Center is a clinical research site located in Gettysburg, Pennsylvania, United States 17325.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Gettysburg Cancer Center has participated in 47 clinical trials with 3 currently active.
Therapeutic areas: PI3K Pathway Activated Tumors, Chronic Myeloid Leukemia, Ovarian Cancer.
Sponsors: Novartis Pharmaceuticals, Ariad Pharmaceuticals, Morphotek.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Gettysburg
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gettysburg Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gettysburg Cancer Center has 47 clinical trials on record, with 3 currently active. Their work covers PI3K Pathway Activated Tumors, Chronic Myeloid Leukemia, Ovarian Cancer.
Gettysburg Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.